Cogent Biosciences

COGTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.450 B

$31.41 -3.74%

Close of 23 Sept 2026

Revenue

—

Not reported

Earnings

-$328.9M

Loss-making

Shares outstanding

173,524,982

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#50Mirum PharmaceuticalsMIRM$5.80B
#51Travere TherapeuticsTVTX$5.64B
#52Cogent BiosciencesCOGT$5.45B
#53Dianthus TherapeuticsDNTH$5.23B
#54Ptc TherapeuticsPTCT$5.20B

What if Cogent Biosciences were worth as much as…

Open the what-if tool →

Gold $29.8T

$172,003.63

Per share 5,476× higher

Bitcoin $1.69T

$9,762.98

Per share 311× higher

Nvidia $5.43T

$31,319.93

Per share 997× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Cogent Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.